Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion type Assertion NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_head.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion description "[By analyzing perturbing mechanism in these two pathways, we identified several reversal gene pairs, including NRAS (neuroblastoma RAS) and CDK2 (cyclin-dependent kinase 2), CCND1 (cyclin D1) and FGFR (fibroblast growth factor receptor).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_provenance.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion evidence source_evidence_literature NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_provenance.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion SIO_000772 24967941 NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_provenance.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion wasDerivedFrom befree-20150227 NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_provenance.
- NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_assertion wasGeneratedBy ECO_0000203 NP301030.RAXiBfyhsU0bAZyCA1lavJB5J2W80YeNpf_bRfUwOrxWU130_provenance.